How IV Ketamine Therapy Works for Treatment-Resistant Depression: A Clinical Guide for Moorestown Patients

For individuals living with depression that has not responded to conventional medications, the search for effective relief can feel exhausting and isolating. An estimated 15% of New Jersey residents experience depression, and a significant portion of those cases are classified as treatment-resistant, meaning two or more standard antidepressant trials have failed to produce adequate improvement. In 2026, ketamine therapy for depression has emerged as one of the most studied and promising options for patients who have not found relief through traditional approaches. At Restorativ Wellness in Moorestown, New Jersey, IV ketamine is administered in a supervised clinical environment as part of a structured treatment plan designed to help patients manage their symptoms and regain a sense of stability.

This guide provides an in-depth look at how IV ketamine works at the neurological level, what the treatment process involves, and who may be a candidate for this therapy.

Understanding Treatment-Resistant Depression

Treatment-resistant depression, often abbreviated as TRD, is generally defined as major depressive disorder that has not responded adequately to at least two different antidepressant medications prescribed at proper dosages and durations. For the millions of Americans affected by TRD, the condition can profoundly impact daily functioning, relationships, career performance, and overall quality of life.

Traditional antidepressants, such as SSRIs and SNRIs, primarily work by modulating serotonin and norepinephrine levels in the brain. While these medications help many patients, research consistently shows that roughly 30% of individuals with major depression do not achieve remission after multiple medication trials. This gap in treatment efficacy has driven clinical interest toward alternative mechanisms of action, with IV ketamine representing one of the most significant developments in psychiatric treatment in recent decades.

Why Standard Antidepressants May Fall Short

Standard antidepressants typically require four to eight weeks to produce noticeable effects, and their mechanism of action targets only a portion of the neurochemical pathways involved in depression. For patients with TRD, this delayed onset and limited scope can mean months or even years of trial and error with various medications, dosages, and combinations. IV ketamine operates through an entirely different pathway, which helps explain why it may benefit patients who have not responded to conventional treatments.

How IV Ketamine Works at the Neurological Level

Unlike traditional antidepressants, ketamine acts primarily on the brain’s glutamate system, the most abundant excitatory neurotransmitter system in the central nervous system. Understanding this mechanism is essential for patients considering ketamine therapy for depression, as it illustrates why the treatment may offer a fundamentally different approach to managing depressive symptoms.

NMDA Receptor Blockade

Ketamine functions as an NMDA (N-methyl-D-aspartate) receptor antagonist. By temporarily blocking these receptors, ketamine triggers a cascade of neurochemical events that differ markedly from the mechanisms of SSRIs or SNRIs. This blockade leads to a surge in glutamate release, which in turn activates another type of receptor called AMPA receptors. The activation of AMPA receptors is believed to play a central role in ketamine’s antidepressant effects.

Synaptic Plasticity and Neural Connection Repair

One of the most compelling aspects of IV ketamine treatment is its apparent ability to promote synaptogenesis, the formation of new synaptic connections between neurons. Research has shown that chronic depression is associated with a reduction in synaptic density, particularly in the prefrontal cortex, a brain region critical for mood regulation, decision-making, and emotional processing. Ketamine appears to stimulate the release of brain-derived neurotrophic factor (BDNF), a protein that supports the growth, maintenance, and survival of neurons. This process may help restore neural pathways that have been weakened or damaged by prolonged depression.

Rapid Onset of Symptom Relief

Perhaps the most notable clinical distinction of IV ketamine is the speed at which patients may notice changes. While traditional antidepressants can take weeks to produce effects, many patients receiving IV ketamine report experiencing improvement in depressive symptoms within hours to days following their initial infusion. It is important to note that individual responses vary, and not all patients will experience rapid or sustained relief. However, the potential for faster symptom management is one reason clinical interest in ketamine-based depression treatment has grown substantially.

What to Expect During IV Ketamine Treatment at Restorativ Wellness

At Restorativ Wellness, IV ketamine is delivered in a carefully controlled clinical setting under the supervision of trained medical professionals. Patients considering this treatment should understand what the process involves from consultation through the infusion series.

Initial Consultation and Evaluation

Before any treatment begins, patients undergo a thorough evaluation to determine whether IV ketamine is appropriate for their specific situation. This assessment typically includes a review of medical history, current medications, prior treatment responses, and the nature and severity of depressive symptoms. The clinical team at Restorativ Wellness uses this information to develop an individualized treatment plan tailored to each patient’s needs.

The Infusion Process

During an IV ketamine session, the medication is administered intravenously over a period typically lasting approximately 40 to 60 minutes. Patients are monitored throughout the entire infusion by clinical staff who track vital signs and overall comfort. The IV delivery method allows for precise dosage control, ensuring that the medication reaches the bloodstream at a consistent and controlled rate.

Most treatment protocols involve a series of infusions rather than a single session. A common initial protocol consists of six infusions administered over a two- to three-week period, though the exact schedule may vary based on individual response and the clinical team’s recommendations. Following the initial series, some patients benefit from periodic maintenance infusions to help sustain their progress.

During and After the Session

Patients may experience mild dissociative effects, changes in perception, or a sense of relaxation during the infusion. These effects are temporary and typically resolve within one to two hours after the session concludes. Patients are advised not to drive on the day of treatment and should arrange transportation to and from their appointment. The clinical team at Restorativ Wellness provides guidance on post-infusion care and monitors patient progress throughout the entire treatment course.

Who May Be a Candidate for IV Ketamine Treatment

Ketamine therapy for depression is generally considered for adults who meet specific clinical criteria. Understanding who may benefit from this treatment can help patients and their referring providers make informed decisions.

Potential candidates typically include individuals who:

• Have been diagnosed with major depressive disorder or treatment-resistant depression
• Have tried two or more antidepressant medications without adequate improvement
• Are seeking an adjunctive treatment to complement their existing mental health care
• Do not have certain medical contraindications, such as uncontrolled hypertension or active substance use disorders

Beyond depression, IV ketamine has also been studied and utilized in clinical settings for conditions including chronic pain, PTSD, anxiety disorders, and OCD. Patients in Moorestown and throughout the greater South Jersey region who are exploring options beyond conventional medications may find that a consultation with the team at Restorativ Wellness can help clarify whether this treatment aligns with their clinical needs.

Safety Profile, Side Effects, and Current Research

As with any medical treatment, understanding the safety profile of IV ketamine is an important part of making an informed decision. Ketamine has been used in medical settings as an anesthetic for over five decades, and its safety profile at subanesthetic doses used for mood disorders has been extensively studied.

Common Side Effects

The most frequently reported side effects during IV ketamine infusions include:

• Mild nausea
• Dizziness or lightheadedness
• Temporary increases in blood pressure or heart rate
• Dissociative or perceptual changes during the infusion
• Fatigue following the session

These effects are generally transient, resolving shortly after the infusion is complete. Because treatments at Restorativ Wellness are administered in a supervised medical environment, the clinical team can address any side effects in real time and adjust treatment parameters as needed.

What the Research Indicates in 2026

The body of clinical evidence supporting IV ketamine for treatment-resistant depression continues to expand. Multiple peer-reviewed studies and clinical trials have demonstrated that a significant percentage of patients with TRD experience meaningful symptom improvement following a course of IV ketamine infusions. Research has shown response rates that are notably higher than those associated with standard antidepressant medications for treatment-resistant cases. It is important to emphasize, however, that results vary among individuals, and ketamine therapy for depression is most effective when integrated into a comprehensive mental health treatment plan that may include psychotherapy, lifestyle modifications, and ongoing clinical support.

As of 2026, clinical guidelines increasingly recognize IV ketamine as a viable treatment option for TRD, and ongoing research continues to refine best practices for dosing protocols, maintenance schedules, and patient selection criteria.

A Comprehensive Approach to Treatment-Resistant Depression in Moorestown

Managing treatment-resistant depression effectively often requires a multifaceted approach. IV ketamine is not intended to replace other forms of mental health care but rather to serve as an additional component of a broader treatment strategy. At Restorativ Wellness, the clinical team works collaboratively with patients and their existing providers to ensure that ketamine treatment is integrated into an overall plan that supports long-term well-being.

For residents of Moorestown, Burlington County, and the surrounding South Jersey communities, access to advanced treatment options like IV ketamine can make a meaningful difference in the management of depression that has not responded to other interventions. Ketamine therapy for depression represents a clinically supported option that has helped many patients take a significant step forward in their mental health journey.

If you or someone you care about is living with treatment-resistant depression and would like to learn more about whether IV ketamine may be appropriate, Restorativ Wellness offers consultations to discuss individual circumstances and treatment options. Contact Restorativ Wellness in Moorestown, New Jersey, to schedule a consultation and take the first step toward exploring this treatment with an experienced clinical team.